IMC-A12 enters Phase II in Advanced Liver Cancer

ImClone’s IGF-1R receptor MAb has entered Phase II trials for Advanced Liver Cancer. It is already in Phase II trials in other cancers including Colorectal and Prostate cancer

Poniard licenses kinase inhibitors from Scripps

Poniard Pharmaceuticals has licensed undisclosed kinas inhibitors from the Scripsp Institute. The inhibitors were previously the focus of a joint research effort

SP-600125 in complex with the mitotic checkpoint kinase Mps1

University of Manchester scientists have publsihed data Celgenes JNK inhibitor SP-600125 in complex with the mitotic checkpoint kinase Mps1